A prospective study of the usefulness of next-generation sequencing, circulating tumor DNA (ctDNA), and exosome DNA as biomarkers in esophageal squamous cell carcinoma
Not Applicable
- Conditions
- esophageal squamous cell cancer
- Registration Number
- JPRN-UMIN000045311
- Lead Sponsor
- Wakayama medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The patients follow our standard treatment protocol of esophageal squamous cell carcinoma.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The correlation of the dose of ctDNA and exosome DNA during treatment and the survival.
- Secondary Outcome Measures
Name Time Method